Table 1. Distribution of the HIV/AIDS cohort of HIV-infected patients based on eGFR categories.
| CKD stage, eGFR (MDRD), mL/min/1.73 m2 | n (%) | |||||
|---|---|---|---|---|---|---|
| Total | M | F | ||||
| Stage 1 (≥90) | 271 (59.7) | 254 (59.6) | 17 (60.7) | |||
| Stage 2 (60–89) | 159 (35.0) | 151 (35.2) | 9 (32.1) | |||
| Stage 3a (45–59) | 18 (4.0) | 17 (4.0) | 1 (3.6) | |||
| Stage 3b (30–44) | 4 (0.9) | 3 (0.7) | 1 (3.6) | |||
| Stage 4 (15–29) | 1 (0.2) | 1 (0.2) | 0 (0.0) | |||
| Stage 5 (<15) | 1 (0.2) | 1 (0.2) | 0 (0.0) | |||
| Total | 454 (100.0) | 426 (93.8) | 28 (6.2) | |||
HIV, human immunodeficiency virus; AIDS, acquired immune deficiency syndrome; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; MDRD, modification of diet in renal disease; M, male; F, female.